English
简体中文
Total: £ 56.28
Published Date: 2026-03-25 | Pages: 120 | Tables: 118 | Pharma & Healthcare
The global Tetanus Vaccine (Adsorbed) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Tetanus Vaccine (Adsorbed) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Tetanus Vaccine (Adsorbed) is a preparation of Tetanus formol toxoid adsorbed on aluminium phosphate gel. Thiomersal is used as a preservative. The potency is not less than 40 International Units per single human dose.
The North American market for Tetanus Vaccine (Adsorbed) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Tetanus Vaccine (Adsorbed) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Tetanus Vaccine (Adsorbed) include Sanofi Pasteur, GSK, Bio Farma, Serum Institute of India, Panacea Biotec, Mitsubishi Tanabe Pharma, KM Biologics, MassBiologics, Chengdu Oulin Biological, Hualan Biological Bacterin, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Tetanus Vaccine (Adsorbed) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Tetanus Vaccine (Adsorbed). The Tetanus Vaccine (Adsorbed) market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Tetanus Vaccine (Adsorbed) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Tetanus Vaccine (Adsorbed) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Sanofi Pasteur
GSK
Bio Farma
Serum Institute of India
Panacea Biotec
Mitsubishi Tanabe Pharma
KM Biologics
MassBiologics
Chengdu Oulin Biological
Hualan Biological Bacterin
Wuhan Biological Products
Segment by Type
Tetanus Vaccine
Combined Vaccine
by Application
Children
Teenager
Adult
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Tetanus Vaccine (Adsorbed) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Tetanus Vaccine (Adsorbed) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Tetanus Vaccine (Adsorbed) Market Overview
1.1 Product Definition
1.2 Tetanus Vaccine (Adsorbed) by Type
1.2.1 Global Tetanus Vaccine (Adsorbed) Market Value by Type: 2025 vs 2032
1.2.2 Tetanus Vaccine
1.2.3 Combined Vaccine
1.3 Tetanus Vaccine (Adsorbed) by Application
1.3.1 Global Tetanus Vaccine (Adsorbed) Market Value by Application: 2025 vs 2032
1.3.2 Children
1.3.3 Teenager
1.3.4 Adult
1.4 Global Tetanus Vaccine (Adsorbed) Market Size Estimates and Forecasts
1.4.1 Global Tetanus Vaccine (Adsorbed) Revenue 2021–2032
1.4.2 Global Tetanus Vaccine (Adsorbed) Sales 2021–2032
1.4.3 Global Tetanus Vaccine (Adsorbed) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Tetanus Vaccine (Adsorbed) Market Competition by Manufacturers
2.1 Global Tetanus Vaccine (Adsorbed) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Tetanus Vaccine (Adsorbed) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Tetanus Vaccine (Adsorbed), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Tetanus Vaccine (Adsorbed), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Tetanus Vaccine (Adsorbed), Product Types and Applications
2.7 Global Key Manufacturers of Tetanus Vaccine (Adsorbed), Date of Entry into the Industry
2.8 Global Tetanus Vaccine (Adsorbed) Market Competitive Situation and Trends
2.8.1 Global Tetanus Vaccine (Adsorbed) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Tetanus Vaccine (Adsorbed) Players Market Share by Revenue
2.8.3 Global Tetanus Vaccine (Adsorbed) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tetanus Vaccine (Adsorbed) Market Scenario by Region
3.1 Global Tetanus Vaccine (Adsorbed) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Tetanus Vaccine (Adsorbed) Sales by Region: 2021–2032
3.2.1 Global Tetanus Vaccine (Adsorbed) Sales by Region: 2021–2026
3.2.2 Global Tetanus Vaccine (Adsorbed) Sales by Region: 2027–2032
3.3 Global Tetanus Vaccine (Adsorbed) Revenue by Region: 2021–2032
3.3.1 Global Tetanus Vaccine (Adsorbed) Revenue by Region: 2021–2026
3.3.2 Global Tetanus Vaccine (Adsorbed) Revenue by Region: 2027–2032
3.4 North America Tetanus Vaccine (Adsorbed) Market Facts & Figures by Country
3.4.1 North America Tetanus Vaccine (Adsorbed) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Tetanus Vaccine (Adsorbed) Sales by Country (2021–2032)
3.4.3 North America Tetanus Vaccine (Adsorbed) Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tetanus Vaccine (Adsorbed) Market Facts & Figures by Country
3.5.1 Europe Tetanus Vaccine (Adsorbed) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Tetanus Vaccine (Adsorbed) Sales by Country (2021–2032)
3.5.3 Europe Tetanus Vaccine (Adsorbed) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tetanus Vaccine (Adsorbed) Market Facts & Figures by Region
3.6.1 Asia Pacific Tetanus Vaccine (Adsorbed) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Tetanus Vaccine (Adsorbed) Sales by Region (2021–2032)
3.6.3 Asia Pacific Tetanus Vaccine (Adsorbed) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tetanus Vaccine (Adsorbed) Market Facts & Figures by Country
3.7.1 Latin America Tetanus Vaccine (Adsorbed) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Tetanus Vaccine (Adsorbed) Sales by Country (2021–2032)
3.7.3 Latin America Tetanus Vaccine (Adsorbed) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tetanus Vaccine (Adsorbed) Market Facts & Figures by Country
3.8.1 Middle East and Africa Tetanus Vaccine (Adsorbed) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Tetanus Vaccine (Adsorbed) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Tetanus Vaccine (Adsorbed) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tetanus Vaccine (Adsorbed) Sales by Type (2021–2032)
4.1.1 Global Tetanus Vaccine (Adsorbed) Sales by Type (2021–2026)
4.1.2 Global Tetanus Vaccine (Adsorbed) Sales by Type (2027–2032)
4.1.3 Global Tetanus Vaccine (Adsorbed) Sales Market Share by Type (2021–2032)
4.2 Global Tetanus Vaccine (Adsorbed) Revenue by Type (2021–2032)
4.2.1 Global Tetanus Vaccine (Adsorbed) Revenue by Type (2021–2026)
4.2.2 Global Tetanus Vaccine (Adsorbed) Revenue by Type (2027–2032)
4.2.3 Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Type (2021–2032)
4.3 Global Tetanus Vaccine (Adsorbed) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Tetanus Vaccine (Adsorbed) Sales by Application (2021–2032)
5.1.1 Global Tetanus Vaccine (Adsorbed) Sales by Application (2021–2026)
5.1.2 Global Tetanus Vaccine (Adsorbed) Sales by Application (2027–2032)
5.1.3 Global Tetanus Vaccine (Adsorbed) Sales Market Share by Application (2021–2032)
5.2 Global Tetanus Vaccine (Adsorbed) Revenue by Application (2021–2032)
5.2.1 Global Tetanus Vaccine (Adsorbed) Revenue by Application (2021–2026)
5.2.2 Global Tetanus Vaccine (Adsorbed) Revenue by Application (2027–2032)
5.2.3 Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Application (2021–2032)
5.3 Global Tetanus Vaccine (Adsorbed) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Company Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur Tetanus Vaccine (Adsorbed) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sanofi Pasteur Tetanus Vaccine (Adsorbed) Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Tetanus Vaccine (Adsorbed) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 GSK Tetanus Vaccine (Adsorbed) Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Bio Farma
6.3.1 Bio Farma Company Information
6.3.2 Bio Farma Description and Business Overview
6.3.3 Bio Farma Tetanus Vaccine (Adsorbed) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bio Farma Tetanus Vaccine (Adsorbed) Product Portfolio
6.3.5 Bio Farma Recent Developments/Updates
6.4 Serum Institute of India
6.4.1 Serum Institute of India Company Information
6.4.2 Serum Institute of India Description and Business Overview
6.4.3 Serum Institute of India Tetanus Vaccine (Adsorbed) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Serum Institute of India Tetanus Vaccine (Adsorbed) Product Portfolio
6.4.5 Serum Institute of India Recent Developments/Updates
6.5 Panacea Biotec
6.5.1 Panacea Biotec Company Information
6.5.2 Panacea Biotec Description and Business Overview
6.5.3 Panacea Biotec Tetanus Vaccine (Adsorbed) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Panacea Biotec Tetanus Vaccine (Adsorbed) Product Portfolio
6.5.5 Panacea Biotec Recent Developments/Updates
6.6 Mitsubishi Tanabe Pharma
6.6.1 Mitsubishi Tanabe Pharma Company Information
6.6.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.6.3 Mitsubishi Tanabe Pharma Tetanus Vaccine (Adsorbed) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Mitsubishi Tanabe Pharma Tetanus Vaccine (Adsorbed) Product Portfolio
6.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.7 KM Biologics
6.7.1 KM Biologics Company Information
6.7.2 KM Biologics Description and Business Overview
6.7.3 KM Biologics Tetanus Vaccine (Adsorbed) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 KM Biologics Tetanus Vaccine (Adsorbed) Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 MassBiologics
6.8.1 MassBiologics Company Information
6.8.2 MassBiologics Description and Business Overview
6.8.3 MassBiologics Tetanus Vaccine (Adsorbed) Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 MassBiologics Tetanus Vaccine (Adsorbed) Product Portfolio
6.8.5 MassBiologics Recent Developments/Updates
6.9 Chengdu Oulin Biological
6.9.1 Chengdu Oulin Biological Company Information
6.9.2 Chengdu Oulin Biological Description and Business Overview
6.9.3 Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Product Portfolio
6.9.5 Chengdu Oulin Biological Recent Developments/Updates
6.10 Hualan Biological Bacterin
6.10.1 Hualan Biological Bacterin Company Information
6.10.2 Hualan Biological Bacterin Description and Business Overview
6.10.3 Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Product Portfolio
6.10.5 Hualan Biological Bacterin Recent Developments/Updates
6.11 Wuhan Biological Products
6.11.1 Wuhan Biological Products Company Information
6.11.2 Wuhan Biological Products Description and Business Overview
6.11.3 Wuhan Biological Products Tetanus Vaccine (Adsorbed) Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Wuhan Biological Products Tetanus Vaccine (Adsorbed) Product Portfolio
6.11.5 Wuhan Biological Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tetanus Vaccine (Adsorbed) Industry Chain Analysis
7.2 Tetanus Vaccine (Adsorbed) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tetanus Vaccine (Adsorbed) Production Mode & Process Analysis
7.4 Tetanus Vaccine (Adsorbed) Sales and Marketing
7.4.1 Tetanus Vaccine (Adsorbed) Sales Channels
7.4.2 Tetanus Vaccine (Adsorbed) Distributors
7.5 Tetanus Vaccine (Adsorbed) Customer Analysis
8 Tetanus Vaccine (Adsorbed) Market Dynamics
8.1 Tetanus Vaccine (Adsorbed) Industry Trends
8.2 Tetanus Vaccine (Adsorbed) Market Drivers
8.3 Tetanus Vaccine (Adsorbed) Market Challenges
8.4 Tetanus Vaccine (Adsorbed) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Tetanus Vaccine (Adsorbed) Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Tetanus Vaccine (Adsorbed) Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Tetanus Vaccine (Adsorbed) Market Competitive Situation by Manufacturers in 2025
Table 4. Global Tetanus Vaccine (Adsorbed) Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Tetanus Vaccine (Adsorbed) Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Tetanus Vaccine (Adsorbed) Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Tetanus Vaccine (Adsorbed) Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Tetanus Vaccine (Adsorbed), Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Tetanus Vaccine (Adsorbed), Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Tetanus Vaccine (Adsorbed), Product Types and Applications
Table 12. Global Key Manufacturers of Tetanus Vaccine (Adsorbed), Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tetanus Vaccine (Adsorbed) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Tetanus Vaccine (Adsorbed) Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tetanus Vaccine (Adsorbed) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Tetanus Vaccine (Adsorbed) Sales by Region (K Dose), 2021–2026
Table 18. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Region (2021–2026)
Table 19. Global Tetanus Vaccine (Adsorbed) Sales by Region (K Dose), 2027–2032
Table 20. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Region (2027–2032)
Table 21. Global Tetanus Vaccine (Adsorbed) Revenue by Region (US$ Million), 2021–2026
Table 22. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Region (2021–2026)
Table 23. Global Tetanus Vaccine (Adsorbed) Revenue by Region (US$ Million), 2027–2032
Table 24. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Region (2027–2032)
Table 25. North America Tetanus Vaccine (Adsorbed) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Tetanus Vaccine (Adsorbed) Sales by Country (K Dose), 2021–2026
Table 27. North America Tetanus Vaccine (Adsorbed) Sales by Country (K Dose), 2027–2032
Table 28. North America Tetanus Vaccine (Adsorbed) Revenue by Country (US$ Million), 2021–2026
Table 29. North America Tetanus Vaccine (Adsorbed) Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Tetanus Vaccine (Adsorbed) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Tetanus Vaccine (Adsorbed) Sales by Country (K Dose), 2021–2026
Table 32. Europe Tetanus Vaccine (Adsorbed) Sales by Country (K Dose), 2027–2032
Table 33. Europe Tetanus Vaccine (Adsorbed) Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Tetanus Vaccine (Adsorbed) Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Tetanus Vaccine (Adsorbed) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Tetanus Vaccine (Adsorbed) Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Tetanus Vaccine (Adsorbed) Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Tetanus Vaccine (Adsorbed) Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Tetanus Vaccine (Adsorbed) Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Tetanus Vaccine (Adsorbed) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Tetanus Vaccine (Adsorbed) Sales by Country (K Dose), 2021–2026
Table 42. Latin America Tetanus Vaccine (Adsorbed) Sales by Country (K Dose), 2027–2032
Table 43. Latin America Tetanus Vaccine (Adsorbed) Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Tetanus Vaccine (Adsorbed) Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Tetanus Vaccine (Adsorbed) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Tetanus Vaccine (Adsorbed) Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Tetanus Vaccine (Adsorbed) Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Tetanus Vaccine (Adsorbed) Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Tetanus Vaccine (Adsorbed) Revenue by Country (US$ Million), 2027–2032
Table 50. Global Tetanus Vaccine (Adsorbed) Sales (K Dose) by Type (2021–2026)
Table 51. Global Tetanus Vaccine (Adsorbed) Sales (K Dose) by Type (2027–2032)
Table 52. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Type (2021–2026)
Table 53. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Type (2027–2032)
Table 54. Global Tetanus Vaccine (Adsorbed) Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Tetanus Vaccine (Adsorbed) Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Type (2021–2026)
Table 57. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Type (2027–2032)
Table 58. Global Tetanus Vaccine (Adsorbed) Price (US$/Dose) by Type (2021–2026)
Table 59. Global Tetanus Vaccine (Adsorbed) Price (US$/Dose) by Type (2027–2032)
Table 60. Global Tetanus Vaccine (Adsorbed) Sales (K Dose) by Application (2021–2026)
Table 61. Global Tetanus Vaccine (Adsorbed) Sales (K Dose) by Application (2027–2032)
Table 62. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Application (2021–2026)
Table 63. Global Tetanus Vaccine (Adsorbed) Sales Market Share by Application (2027–2032)
Table 64. Global Tetanus Vaccine (Adsorbed) Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Tetanus Vaccine (Adsorbed) Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Application (2021–2026)
Table 67. Global Tetanus Vaccine (Adsorbed) Revenue Market Share by Application (2027–2032)
Table 68. Global Tetanus Vaccine (Adsorbed) Price (US$/Dose) by Application (2021–2026)
Table 69. Global Tetanus Vaccine (Adsorbed) Price (US$/Dose) by Application (2027–2032)
Table 70. Sanofi Pasteur Company Information
Table 71. Sanofi Pasteur Description and Business Overview
Table 72. Sanofi Pasteur Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Sanofi Pasteur Tetanus Vaccine (Adsorbed) Product
Table 74. Sanofi Pasteur Recent Developments/Updates
Table 75. GSK Company Information
Table 76. GSK Description and Business Overview
Table 77. GSK Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. GSK Tetanus Vaccine (Adsorbed) Product
Table 79. GSK Recent Developments/Updates
Table 80. Bio Farma Company Information
Table 81. Bio Farma Description and Business Overview
Table 82. Bio Farma Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Bio Farma Tetanus Vaccine (Adsorbed) Product
Table 84. Bio Farma Recent Developments/Updates
Table 85. Serum Institute of India Company Information
Table 86. Serum Institute of India Description and Business Overview
Table 87. Serum Institute of India Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Serum Institute of India Tetanus Vaccine (Adsorbed) Product
Table 89. Serum Institute of India Recent Developments/Updates
Table 90. Panacea Biotec Company Information
Table 91. Panacea Biotec Description and Business Overview
Table 92. Panacea Biotec Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Panacea Biotec Tetanus Vaccine (Adsorbed) Product
Table 94. Panacea Biotec Recent Developments/Updates
Table 95. Mitsubishi Tanabe Pharma Company Information
Table 96. Mitsubishi Tanabe Pharma Description and Business Overview
Table 97. Mitsubishi Tanabe Pharma Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Mitsubishi Tanabe Pharma Tetanus Vaccine (Adsorbed) Product
Table 99. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 100. KM Biologics Company Information
Table 101. KM Biologics Description and Business Overview
Table 102. KM Biologics Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. KM Biologics Tetanus Vaccine (Adsorbed) Product
Table 104. KM Biologics Recent Developments/Updates
Table 105. MassBiologics Company Information
Table 106. MassBiologics Description and Business Overview
Table 107. MassBiologics Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. MassBiologics Tetanus Vaccine (Adsorbed) Product
Table 109. MassBiologics Recent Developments/Updates
Table 110. Chengdu Oulin Biological Company Information
Table 111. Chengdu Oulin Biological Description and Business Overview
Table 112. Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. Chengdu Oulin Biological Tetanus Vaccine (Adsorbed) Product
Table 114. Chengdu Oulin Biological Recent Developments/Updates
Table 115. Hualan Biological Bacterin Company Information
Table 116. Hualan Biological Bacterin Description and Business Overview
Table 117. Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 118. Hualan Biological Bacterin Tetanus Vaccine (Adsorbed) Product
Table 119. Hualan Biological Bacterin Recent Developments/Updates
Table 120. Wuhan Biological Products Company Information
Table 121. Wuhan Biological Products Description and Business Overview
Table 122. Wuhan Biological Products Tetanus Vaccine (Adsorbed) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 123. Wuhan Biological Products Tetanus Vaccine (Adsorbed) Product
Table 124. Wuhan Biological Products Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Tetanus Vaccine (Adsorbed) Distributors List
Table 128. Tetanus Vaccine (Adsorbed) Customers List
Table 129. Tetanus Vaccine (Adsorbed) Market Trends
Table 130. Tetanus Vaccine (Adsorbed) Market Drivers
Table 131. Tetanus Vaccine (Adsorbed) Market Challenges
Table 132. Tetanus Vaccine (Adsorbed) Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tetanus Vaccine (Adsorbed)
Figure 2. Global Tetanus Vaccine (Adsorbed) Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Tetanus Vaccine (Adsorbed) Market Share by Type: 2025 & 2032
Figure 4. Tetanus Vaccine Product Picture
Figure 5. Combined Vaccine Product Picture
Figure 6. Global Tetanus Vaccine (Adsorbed) Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Tetanus Vaccine (Adsorbed) Market Share by Application: 2025 & 2032
Figure 8. Children
Figure 9. Teenager
Figure 10. Adult
Figure 11. Global Tetanus Vaccine (Adsorbed) Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Tetanus Vaccine (Adsorbed) Market Size (US$ Million), 2021–2032
Figure 13. Global Tetanus Vaccine (Adsorbed) Sales (K Dose), 2021–2032
Figure 14. Global Tetanus Vaccine (Adsorbed) Average Price (US$/Dose), 2021–2032
Figure 15. Tetanus Vaccine (Adsorbed) Report Years Considered
Figure 16. Tetanus Vaccine (Adsorbed) Sales Share by Manufacturers in 2025
Figure 17. Global Tetanus Vaccine (Adsorbed) Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Tetanus Vaccine (Adsorbed) Players: Market Share by Revenue in Tetanus Vaccine (Adsorbed) in 2025
Figure 19. Tetanus Vaccine (Adsorbed) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Tetanus Vaccine (Adsorbed) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Tetanus Vaccine (Adsorbed) Sales Market Share by Country (2021–2032)
Figure 22. North America Tetanus Vaccine (Adsorbed) Revenue Market Share by Country (2021–2032)
Figure 23. United States Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Tetanus Vaccine (Adsorbed) Sales Market Share by Country (2021–2032)
Figure 26. Europe Tetanus Vaccine (Adsorbed) Revenue Market Share by Country (2021–2032)
Figure 27. Germany Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Tetanus Vaccine (Adsorbed) Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Tetanus Vaccine (Adsorbed) Revenue Market Share by Region (2021–2032)
Figure 34. China Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Tetanus Vaccine (Adsorbed) Sales Market Share by Country (2021–2032)
Figure 42. Latin America Tetanus Vaccine (Adsorbed) Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Tetanus Vaccine (Adsorbed) Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Tetanus Vaccine (Adsorbed) Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Tetanus Vaccine (Adsorbed) Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Tetanus Vaccine (Adsorbed) by Type (2021–2032)
Figure 53. Global Revenue Market Share of Tetanus Vaccine (Adsorbed) by Type (2021–2032)
Figure 54. Global Tetanus Vaccine (Adsorbed) Price (US$/Dose) by Type (2021–2032)
Figure 55. Global Sales Market Share of Tetanus Vaccine (Adsorbed) by Application (2021–2032)
Figure 56. Global Revenue Market Share of Tetanus Vaccine (Adsorbed) by Application (2021–2032)
Figure 57. Global Tetanus Vaccine (Adsorbed) Price (US$/Dose) by Application (2021–2032)
Figure 58. Tetanus Vaccine (Adsorbed) Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
